Approval
Posted: Sun Jan 20, 2019 1:04 am
Without a major firms marketing, sales force, contacts and it's own reputation, approval of this drug is, in and of itself, not a blanket guarantee that it will have a commercial success. One of the downsides of the loss of the JnJ partnership. Going it alone, through the P3, and beyond ....to the market, will present little GERON with a unique set of challenges. Ones that they have not encountered before. But I'm sure would welcome.